Taiwan · Delayed Price · Currency is TWD Genovate Biotechnology Statistics
Total Valuation
TPEX:4130 has a market cap or net worth of TWD 2.14 billion. The enterprise value is 1.63 billion.
| Market Cap | 2.14B |
| Enterprise Value | 1.63B |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Aug 21, 2024 |
Share Statistics
TPEX:4130 has 111.52 million shares outstanding. The number of shares has decreased by -0.51% in one year.
| Current Share Class | 111.52M |
| Shares Outstanding | 111.52M |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 0.33% |
| Owned by Institutions (%) | 1.23% |
| Float | 79.06M |
Valuation Ratios
The trailing PE ratio is 115.33.
| PE Ratio | 115.33 |
| Forward PE | n/a |
| PS Ratio | 4.25 |
| PB Ratio | 1.49 |
| P/TBV Ratio | 1.50 |
| P/FCF Ratio | 35.99 |
| P/OCF Ratio | 20.69 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.81, with an EV/FCF ratio of 27.49.
| EV / Earnings | 87.67 |
| EV / Sales | 3.24 |
| EV / EBITDA | 32.81 |
| EV / EBIT | 122.93 |
| EV / FCF | 27.49 |
Financial Position
The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.78 |
| Quick Ratio | 3.87 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.04 |
| Interest Coverage | 20.93 |
Financial Efficiency
Return on equity (ROE) is 1.27% and return on invested capital (ROIC) is 0.61%.
| Return on Equity (ROE) | 1.27% |
| Return on Assets (ROA) | 0.56% |
| Return on Invested Capital (ROIC) | 0.61% |
| Return on Capital Employed (ROCE) | 1.00% |
| Revenue Per Employee | 2.63M |
| Profits Per Employee | 97,408 |
| Employee Count | 195 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 2.39 |
Taxes
In the past 12 months, TPEX:4130 has paid 3.88 million in taxes.
| Income Tax | 3.88M |
| Effective Tax Rate | 17.27% |
Stock Price Statistics
The stock price has decreased by -18.51% in the last 52 weeks. The beta is 0.26, so TPEX:4130's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -18.51% |
| 50-Day Moving Average | 20.56 |
| 200-Day Moving Average | 21.75 |
| Relative Strength Index (RSI) | 33.03 |
| Average Volume (20 Days) | 50,766 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4130 had revenue of TWD 502.80 million and earned 18.61 million in profits. Earnings per share was 0.17.
| Revenue | 502.80M |
| Gross Profit | 183.86M |
| Operating Income | 14.36M |
| Pretax Income | 22.49M |
| Net Income | 18.61M |
| EBITDA | 49.70M |
| EBIT | 14.36M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 507.12 million in cash and 2.55 million in debt, giving a net cash position of 504.57 million or 4.52 per share.
| Cash & Cash Equivalents | 507.12M |
| Total Debt | 2.55M |
| Net Cash | 504.57M |
| Net Cash Per Share | 4.52 |
| Equity (Book Value) | 1.43B |
| Book Value Per Share | 12.82 |
| Working Capital | 589.68M |
Cash Flow
In the last 12 months, operating cash flow was 103.23 million and capital expenditures -43.89 million, giving a free cash flow of 59.34 million.
| Operating Cash Flow | 103.23M |
| Capital Expenditures | -43.89M |
| Free Cash Flow | 59.34M |
| FCF Per Share | 0.53 |
Margins
Gross margin is 36.57%, with operating and profit margins of 2.86% and 3.70%.
| Gross Margin | 36.57% |
| Operating Margin | 2.86% |
| Pretax Margin | 4.47% |
| Profit Margin | 3.70% |
| EBITDA Margin | 9.88% |
| EBIT Margin | 2.86% |
| FCF Margin | 11.80% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.52%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | -11.71% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 88.18% |
| Buyback Yield | 0.51% |
| Shareholder Yield | 1.03% |
| Earnings Yield | 0.87% |
| FCF Yield | 2.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 21, 2024. It was a forward split with a ratio of 1.03.
| Last Split Date | Aug 21, 2024 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
TPEX:4130 has an Altman Z-Score of 10.51 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.51 |
| Piotroski F-Score | 4 |